DESREM - Mylan
For adverse events/product quality-related information, contact: ProductSafety@mylan.com i

LICENSED COUNTRIES FOR SALE OF REMDESIVIR

To be sold in licensed countries as mentioned below:

Licensed Countries
Afghanistan Fiji Niger
Algeria Gabon Nigeria
Angola Gambia, The Pakistan
Anguilla Georgia Palau
Antigua & Barbuda Ghana Panama
Armenia Grenada Papua New Guinea
Aruba Guatemala Philippines
Azerbaijan Guinea Rwanda
Bahamas Guinea Bis Samoa
Bangladesh Guyana Sao Tome and Principe
Barbados Haiti Senegal
Belarus Honduras Seychelles
Belize India Sierra Leone
Benin Indonesia Sint Maarten (Dutch part)
Bermuda Jamaica Solomon Islands
Bhutan Kazakhstan Somalia
Botswana Kenya South Africa
British Virgin Islands Kiribati South Sudan
Burkina Faso Korea, Dem. People’s Rep. (North Korea) Sri Lanka
Burundi Kyrgyzstan St. Kitts and Nevis
Cambodia Lao DR (Laos) St. Lucia
Cameroon Lesotho St. Vincent and the Grenadines
Cape Verde Liberia Sudan
Cayman Island Libya Suriname
Central Af R. Madagascar Tajikistan
Chad Malawi Tanzania
Comoros Maldives Thailand
Congo, Dem. Rep. Mali Timor-Leste
Congo Rep. Marshall Islands Togo
Costa Rica Mauritania Tonga
Cook Islands Mauritius Trinidad & Tobago
Cote d’Ivoire Micronesia, Fed. Sts. Tunisia
Cuba Moldova Turkmenistan
Curacao Mongolia Turks & Caicos
Djibouti Montserrat Tuvalu
Dominica Morocco Uganda
Dominican Republic Mozambique Ukraine
Egypt Myanmar Uzbekistan
El Salvador Namibia Vanuatu
Equatorial Guinea Nauru Vietnam
Eritrea Nepal Zambia
Eswatini (Swaziland) Nicaragua Zimbabwe
Ethiopia
DESREM™, Remdesivir Prescribing Information. Mylan Laboratories Limited. 2020.